Crohn’s Disease and Ulcerative Colitis stem cell therapy
6. Crohn’s Disease Intravenous infusion of autologous MSCs has demonstrated significant efficacy in managing Crohn’s disease by reducing abdominal pain, improving bowel function, and reducing inflammation. MSCs modulate immune responses by suppressing pro-inflammatory cytokines, enhancing regulatory T-cell activity, and promoting mucosal healing. The paracrine signaling of MSCs stimulates epithelial regeneration Read more





